Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: gout

Tips for Rheumatologists to Master Quality Measurement in Clinical Practice

Susan Bernstein  |  February 15, 2017

WASHINGTON, D.C.—In 2017, rheumatologists will begin to track and report quality data for reimbursement under the the Medicare and CHIP Reauthorization Act of 2015 (MACRA). Panelists shared their tips on how to score more points under MACRA and utilize existing technology at a Nov. 14 session called Implementing Quality Measurement in Your Clinical Practice at…

Filed under:Meeting ReportsPractice Support Tagged with:2016 ACR/ARHP Annual MeetingBillingClinical PracticeCodingMACRAMedicaremerit-based incentiveMIPSpatient carePractice ManagementQualityReimbursementrheumatologistrheumatologyRISE registry

The ACR’s 2015 Workforce Study Reveals Gap Between Rheumatologist Supply, Patient Demand

Susan Bernstein  |  February 15, 2017

WASHINGTON, D.C.—In the next 15 years, it will be increasingly difficult to provide adequate care for rising numbers of patients with rheumatic diseases due to a severe shortage of trained rheumatology healthcare providers, according to the ACR’s 2015 Workforce Study of Rheumatology Specialists in the United States. The full study is available online, and panelists…

Filed under:ConditionsMeeting ReportsPediatric ConditionsWorkforce Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)patient carePediatricphysician supplyQualityRheumatic Diseaserheumatologistrheumatologyshortage

When Symptoms of Rheumatic Disorder Point to Endocrine Disease

Thomas R. Collins  |  February 15, 2017

WASHINGTON, D.C.—“Rheumatic manifestations are [often] the initial presentation of a systemic disease, but they can [also] occur during the course of the disorder,” said Joseph Markenson, MD, speaking in the ACR/ARHP Annual Meeting talk, Rheumatic Manifestations of Endocrine Disease, during the ACR Review Course. Dr. Markenson is professor of clinical medicine and a rheumatologist at Weill…

Filed under:ConditionsMeeting Reports Tagged with:2016 ACR/ARHP Annual MeetingdiabetesDiagnosisendocrine diseasehypothyroid myopathyhypothyroidismmanifestationRheumatic DiseaserheumatologistrheumatologysymptomtherapyTreatment

Baricitinib Is Effective in Patients Treated with DMARDs & Methotrexate

Lara C. Pullen, PhD  |  January 30, 2017

A recent analysis has examined the effectiveness of baricitinib in treating RA patients who suffer from comorbidities and the effect of concomitant use of steroids. Baricitinib proved effective, particularly in patients who had exposure to cDMARDs and corticosteroids…

Filed under:Drug Updates Tagged with:baricitinibDisease-modifying antirheumatic drugs (DMARDs)Janus Kinase InhibitorsMethotrexate

Biomedical Research Key to Advancing Clinical Care for Rheumatic Diseases

Mary Beth Nierengarten  |  January 19, 2017

WASHINGTON, D.C.—The importance of biomedical research to advancing clinical care with the ultimate goal of improving patients’ lives was on display during an ACR Discovery 2016 plenary session at the 2016 ACR/ARHP Annual Meeting. The session offered new ways to think about and treat select rheumatologic diseases, including research showing for the first time the…

Filed under:Axial SpondyloarthritisConditionsMeeting Reports Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)Ankylosing Spondylitisbiomedical researchchronic kidney diseaseClinicalconditionsGiant Cell Arteritisoutcomepatient carePsoriatic ArthritisRheumatic DiseaseStatinSteroidTreatment

Chart a New Course: A Rheumatologist Talks about Practicing in an Orthopedic Environment

Karen Appold  |  December 30, 2016

Working as a rheumatologist in an orthopedic practice has its own unique challenges, but may result in better patient care, according to Sheeja Francis, MD…

Filed under:Career DevelopmentProfessional Topics Tagged with:Career developmentClinical Practicehealth professionalorthopedicpatient careProfessional Topicsrheumatologist

Lesinurad with Allopurinol When Allopurinol Alone Is Insufficient

Arthritis & Rheumatology  |  December 29, 2016

Current guidelines for the long-term management of gout recommend a combination of lifestyle management and/or pharmacotherapy to lower serum UA levels to <6.0 mg/dL in most patients or <5.0 mg/dL in patients with more severe disease. Allopurinol is the most widely used xanthine oxidase inhibitor and is recommended in treatment guidelines as a first-line urate-lowering…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:AllopurinolArthritis & RheumatologyGoutlesinuradResearchUric acid

The 2016 ACR Award Winners Discuss Their Contributions to Rheumatology Research, Education, Patient Care

Richard Quinn  |  December 13, 2016

At the 2016 ACR/ARHP Annual Meeting in Washington, D.C., in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. In the November 2016 issue, we reported on the ARHP’s awards. This month, we speak with the ACR winners. Presidential Gold…

Filed under:Awards Tagged with:AC&RACR/ARHPAmerican College of Rheumatology (ACR)Awardsrheumatologywinner

Obesity & Rheumatic Disease

Richard Quinn  |  December 9, 2016

“Obesity is an inflammatory state, so it is in the landscape of the rheumatologist,” says Christopher Ritchlin, MD, MPH. And the more attention rheumatologists pay to obesity, the better…

Filed under:Conditions Tagged with:DietinflammationObesitypreventiveRheumatic Disease

RISE Registry Promises to Improve Care & Research for Rheumatology

Arthritis Care & Research  |  December 6, 2016

In 2014, the ACR launched the Rheumatology Informatics System for Effectiveness (RISE), a national electronic health record (EHR)-enabled registry. The goal: To help participating rheumatologists and practices leverage the new wave of big data created by the use of EHR, advance research and improve overall quality of care. A new analysis examines the RISE structure and the initial patient data collected by the registry…

Filed under:EMRsResearch RheumTechnology Tagged with:Arthritis Care & ResearchResearchRheumatoid Arthritis (RA)RISERISE registryTechnology

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 59
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences